CEM Corporation

CEM Corporation is committed to the continuous advancement of solid-phase peptide synthesis. Our goal is to develop the most effective and efficient SPPS workflow solutions for the peptide and peptidomimetic community.

Our performance- and efficiency-driven peptide synthesizer lines are available in both sequential and parallel formats, spanning research through production scale synthesis. We offer a suite of high-quality SPPS chemicals, including preloaded resins and amino acids in both bulk and conveniently pre-weighed options.

Our powerful purification system streamlines peptide isolation, simplifying the transition from analytical to preparative scale.

From reagent preparation and peptide synthesis to cleavage and purification, our dedicated team of scientists and engineers strive to simplify science, start to finish.

Contact Us:

Tel: (800) 726-3331

Email: info@cem.com

Welcome to Shenzhen JYMed Technology Co.

We are honored to be exhibiting at the Boulder Peptide Symposium. With some of the largest capacity worldwide at our Hubei facilities, a state-of-the-art R&D center at our Shenzhen facilities, and fill-finish capabilities at our Nanjing facilities, we can handle projects from grams to metric tons, from pre-clinical to consumer-ready.

After excelling in the Asian market, we are making our international debut. Thanks to our highly trained teams and significant investments in capacity, we offer lead times and prices that are often unmatched in the industry. Please visit our booth to see how we can help you save time and money.

We are also proud to announce that JYMed’s peptide production plant recently passed FDA inspections for the third time. This achievement underscores our commitment to maintaining high standards in API production and our dedication to delivering high-quality APIs for clients worldwide.

Shenzhen JYMed Technology Co.,Ltd is a high-tech enterprise engaged in research and development, manufacturing and commercialization of peptides based products including active pharmaceutical ingredient peptides, cosmetic peptides, and custom peptides as well as new peptide drug development. JYMed has two wholly-owned subsidiaries: Shenzhen JYBio Pharmaceutical Co., Ltd and Hubei JY Pharmaceutical Co., Ltd, which is under construction.

Tel:  +86 0755-26612112

Email:  jymed@jymedtech.com

Welcome to Jiuzhou Pharma

Jiuzhou Pharma is a leading contract research and development manufacturing organization (CRDMO) that successfully evolved from a generic API manufacturer to a full-service contract manufacturer of TIDES (peptides & oligos) APIs, small molecule APIs, and Drug Products. We provide pharmaceutical companies with one-stop innovative drug development and manufacturing solutions and services throughout the development lifecycle of an innovative drug—from preclinical chemical manufacturing and control through phase I/II/III clinical trials and new drug applications to commercialization. As a leader in green pharmaceutical manufacturing, we have developed environmentally friendly pharmaceutical technologies. Building end-to-end capabilities and offering integrated solutions in the small molecule and TIDES space is our vision. In 2023, Jiuzhou made major investments at the US headquarters (Brevard, NC) to service the small molecule and TIDES customers involved in research stage and early clinical projects.

Innovative Drug CDMO Service

Tel:86-576-85588039

Email:bd.cdmo@jiuzhoupharma.com

Established Services

Tel:86-576-88881561

Email:sale@jiuzhoupharma.com